274 related articles for article (PubMed ID: 30271345)
1. Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease.
Zhang ZH; Li MH; Liu D; Chen H; Chen DQ; Tan NH; Ma SC; Zhao YY
Front Pharmacol; 2018; 9():1029. PubMed ID: 30271345
[TBL] [Abstract][Full Text] [Related]
2. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
3. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis.
Zhang ZH; Wei F; Vaziri ND; Cheng XL; Bai X; Lin RC; Zhao YY
Sci Rep; 2015 Sep; 5():14472. PubMed ID: 26412413
[TBL] [Abstract][Full Text] [Related]
5. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
6. An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure.
Zhang ZH; Vaziri ND; Wei F; Cheng XL; Bai X; Zhao YY
Sci Rep; 2016 Feb; 6():22151. PubMed ID: 26903149
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
8. Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-β/Smad signaling pathway.
Cai H; Wang J; Luo Y; Wang F; He G; Zhou G; Peng X
Biomed Pharmacother; 2021 Feb; 134():111098. PubMed ID: 33341058
[TBL] [Abstract][Full Text] [Related]
9. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
10. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
Lan HY
Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
12. TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis.
Yu XY; Sun Q; Zhang YM; Zou L; Zhao YY
Front Pharmacol; 2022; 13():860588. PubMed ID: 35401211
[TBL] [Abstract][Full Text] [Related]
13. TGF-β/Smad signaling in renal fibrosis.
Meng XM; Tang PM; Li J; Lan HY
Front Physiol; 2015; 6():82. PubMed ID: 25852569
[TBL] [Abstract][Full Text] [Related]
14. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
16. Smads as therapeutic targets for chronic kidney disease.
Lan HY
Kidney Res Clin Pract; 2012 Mar; 31(1):4-11. PubMed ID: 26889404
[TBL] [Abstract][Full Text] [Related]
17. The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-β1 signaling pathway.
Yao Y; Yang J; Wang D; Zhou F; Cai X; Lu W; Hu C; Gu Z; Qian S; Guan X; Cao P
Phytomedicine; 2013 Oct; 20(13):1160-7. PubMed ID: 23827664
[TBL] [Abstract][Full Text] [Related]
18. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-β1/TGF-β type I receptor/Smads signaling in proximal tubular epithelial cells.
Gu TT; Chen TY; Yang YZ; Zhao XJ; Sun Y; Li TS; Zhang DM; Kong LD
Eur J Pharmacol; 2019 Jan; 842():70-78. PubMed ID: 30336139
[TBL] [Abstract][Full Text] [Related]
20. TGF-β/Smad signaling in kidney disease.
Lan HY; Chung AC
Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
